Suppr超能文献

人类结直肠癌中肿瘤浸润γδ T淋巴细胞的独特特征。

Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer.

作者信息

Meraviglia S, Lo Presti E, Tosolini M, La Mendola C, Orlando V, Todaro M, Catalano V, Stassi G, Cicero G, Vieni S, Fourniè J J, Dieli F

机构信息

Central Laboratory of Advanced Diagnosis and Biomedical Research (CLADIBIOR), University of Palermo, Palermo, Italy.

Department of Biopathology and Medical Biotechnologies (DIBIMED), University of Palermo, Palermo, Italy.

出版信息

Oncoimmunology. 2017 Jul 13;6(10):e1347742. doi: 10.1080/2162402X.2017.1347742. eCollection 2017.

Abstract

γδ T cells usually infiltrate many different types of cancer, but it is unclear whether they inhibit or promote tumor progression. Moreover, properties of tumor-infiltrating γδ T cells and those in the corresponding normal tissue remain largely unknown. Here we have studied features of γδ T cells in colorectal cancer, normal colon tissue and peripheral blood, and correlated their levels with clinicopathologic hallmarks. Flow cytometry and transcriptome analyses showed that the tumor comprised a highly variable rate of TILs (5-90%) and 4% γδ T cells on average, with the majority expressing Vδ1. Most Vδ1 and Vδ2 T cells showed a predominant effector memory phenotype and had reduced production of IFN- γ which was likely due to yet unidentified inhibitory molecules present in cancer stem cell secretome. Transcriptome analyses revealed that patients containing abundant γδ T cells had significantly longer 5-year disease free survival rate, suggesting their efficacy in controlling tumor at very early stage.

摘要

γδ T细胞通常浸润多种不同类型的癌症,但它们是抑制还是促进肿瘤进展尚不清楚。此外,肿瘤浸润性γδ T细胞以及相应正常组织中的γδ T细胞的特性在很大程度上仍然未知。在这里,我们研究了结直肠癌、正常结肠组织和外周血中γδ T细胞的特征,并将它们的水平与临床病理特征相关联。流式细胞术和转录组分析表明,肿瘤中TILs的比例高度可变(5-90%),平均有4%的γδ T细胞,大多数表达Vδ1。大多数Vδ1和Vδ2 T细胞表现出主要的效应记忆表型,并且IFN-γ的产生减少,这可能是由于癌症干细胞分泌组中存在尚未鉴定的抑制分子。转录组分析显示,含有丰富γδ T细胞的患者5年无病生存率显著更长,表明它们在肿瘤极早期阶段具有控制肿瘤的功效。

相似文献

1
Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer.
Oncoimmunology. 2017 Jul 13;6(10):e1347742. doi: 10.1080/2162402X.2017.1347742. eCollection 2017.
3
Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin.
J Exp Med. 1996 Apr 1;183(4):1681-96. doi: 10.1084/jem.183.4.1681.
5
Analysis of tumor-infiltrating gamma delta T cells in rectal cancer.
World J Gastroenterol. 2016 Apr 7;22(13):3573-80. doi: 10.3748/wjg.v22.i13.3573.
8
Squamous Cell Tumors Recruit γδ T Cells Producing either IL17 or IFNγ Depending on the Tumor Stage.
Cancer Immunol Res. 2017 May;5(5):397-407. doi: 10.1158/2326-6066.CIR-16-0348. Epub 2017 Mar 28.

引用本文的文献

1
Harnessing the immunotherapeutic potentials of gamma delta T cells against hematological malignancies.
Hemasphere. 2025 Aug 7;9(8):e70182. doi: 10.1002/hem3.70182. eCollection 2025 Aug.
2
Characteristics and significance of γδ T cells in colorectal cancer.
Oncoimmunology. 2025 Dec;14(1):2532231. doi: 10.1080/2162402X.2025.2532231. Epub 2025 Jul 28.
3
Mechanisms and Functions of γδ T Cells in Tumor Cell Recognition.
Curr Oncol. 2025 Jun 3;32(6):329. doi: 10.3390/curroncol32060329.
5
DOT cells for colorectal cancer immunotherapy.
Nat Cancer. 2025 May 1. doi: 10.1038/s43018-025-00965-8.
7
EphA2 and phosphoantigen-mediated selective killing of medulloblastoma by γδT cells preserves neuronal and stem cell integrity.
Oncoimmunology. 2025 Dec;14(1):2485535. doi: 10.1080/2162402X.2025.2485535. Epub 2025 Apr 7.
9
Gamma delta T cells and their immunotherapeutic potential in cancer.
Biomark Res. 2025 Mar 28;13(1):51. doi: 10.1186/s40364-025-00762-6.

本文引用的文献

1
Assessment of tumor-infiltrating TCRV9V2 lymphocyte abundance by deconvolution of human cancers microarrays.
Oncoimmunology. 2017 Feb 6;6(3):e1284723. doi: 10.1080/2162402X.2017.1284723. eCollection 2017.
2
Ionic immune suppression within the tumour microenvironment limits T cell effector function.
Nature. 2016 Sep 22;537(7621):539-543. doi: 10.1038/nature19364. Epub 2016 Sep 14.
3
Large-scale microarray profiling reveals four stages of immune escape in non-Hodgkin lymphomas.
Oncoimmunology. 2016 May 19;5(7):e1188246. doi: 10.1080/2162402X.2016.1188246. eCollection 2016 Jul.
4
The CXCL8-CXCR1/2 pathways in cancer.
Cytokine Growth Factor Rev. 2016 Oct;31:61-71. doi: 10.1016/j.cytogfr.2016.08.002. Epub 2016 Aug 25.
5
IFNγ-Dependent Interactions between ICAM-1 and LFA-1 Counteract Prostaglandin E2-Mediated Inhibition of Antitumor CTL Responses.
Cancer Immunol Res. 2016 May;4(5):400-11. doi: 10.1158/2326-6066.CIR-15-0146. Epub 2016 Feb 29.
6
Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy.
Clin Cancer Res. 2015 Dec 15;21(24):5427-33. doi: 10.1158/1078-0432.CCR-15-0420. Epub 2015 Oct 30.
7
γδ T cells in cancer.
Nat Rev Immunol. 2015 Nov;15(11):683-91. doi: 10.1038/nri3904. Epub 2015 Oct 9.
8
The prognostic landscape of genes and infiltrating immune cells across human cancers.
Nat Med. 2015 Aug;21(8):938-945. doi: 10.1038/nm.3909. Epub 2015 Jul 20.
9
Robust enumeration of cell subsets from tissue expression profiles.
Nat Methods. 2015 May;12(5):453-7. doi: 10.1038/nmeth.3337. Epub 2015 Mar 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验